Melania Trump’s successful embolization treatment casts spotlight on interventional radiology

First lady Melania Trump underwent an image-guided embolization treatment for a benign kidney condition earlier this week, casting a sudden spotlight on the world of interventional radiology. The small surgery was a success, according to the White House, and she will be recovering at Walter Reed National Military Medical Center for the rest of the week. 

The Society of Intervention Radiology (SIR) issued a statement Tuesday, May 15, to help inform a curious public about what, exactly, the first lady went through. The statement was written by M. Victoria Marx, MD, SIR president and an interventional radiologist at Keck Medicine of USC in Los Angeles.

“The Society of Interventional Radiology wishes the First lady, Melania Trump, a speedy recovery as she recuperates from her embolization treatment,” Marx said in the statement. “Embolization, a treatment created by interventional radiologists (IRs), is an important tool in the toolbox of IRs everywhere. Embolization can be used to stop bleeding, as in cases of trauma, or to starve a fibroid or tumor of its blood supply, as may be the case in the treatment performed on Mrs. Trump.”

Marx also highlighted a major benefit of such procedures—that they save the patient from considerable stress. “The beauty of this solution is that no open surgery is required, reducing both the patient’s risk and recovery time,” she wrote. “In many cases, patients can go home the same day. Sometimes a short stay in the hospital is required, depending upon the patient and area treated.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.